Cart
sales@molnova.com
(-)-Vorozole
CAS No. 132042-69-4
(-)-Vorozole( —— )
Catalog No. M34141 CAS No. 132042-69-4
(-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 172 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 531 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(-)-Vorozole
-
NoteResearch use only, not for human use.
-
Brief Description(-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity.
-
Description(-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potency and selectivity. (-)-Vorozole has demonstrated antitumor activity in in vivo experiments. (-)-Vorozole is used in the study of breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorP450 | Aromatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132042-69-4
-
Formula Weight324.77
-
Molecular FormulaC16H13ClN6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C=1C=C2C(=CC1)N=NN2C)(C3=CC=C(Cl)C=C3)N4C=NC=N4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ginsenoside F1
Ginsenoside F1,an enzymatically modified derivative of ginsenoside Rg1, protection from ultraviolet-B-induced apoptosis is tightly correlated with ginsenoside-F1-mediated inhibition of ultraviolet-B-induced downregulation of Bcl-2 and Brn-3a expression.
-
CYP1B1-IN-1
CYP1B1-IN-1 is a selective and highly potent cytochrome P450 1B1 (CYP1B1) inhibitor with potential anticancer and antitumor activity for breast cancer research.
-
7-Hydroxyflavone
7-Hydroxyflavone is a potent inhibitor of CYP1A1 with a Ki value of 0.015 μM and exhibits 6-fold greater selectivity for CYP1A1 over CYP1A2.with anti-inflammatory activity.
